Literature DB >> 7880127

Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies.

J Matsuda1, N Saitoh, M Gotoh, K Gohchi, M Tsukamoto.   

Abstract

OBJECTIVE: To investigate whether beta 2-glycoprotein I antibody (aGPI) exists in sera that are positive for antiphospholipid antibodies (aPL).
METHODS: Thirty six patients with systemic lupus erythematosus (SLE) and 20 healthy volunteers were recruited. GPI independent and dependent aPL (anticardiolipin (aCL), antiphosphatidylserine, antiphosphatidylinositol, antiphosphatidic acid) were measured using a conventional enzyme linked immunosorbent assay (ELISA). aGPI was measured by an ELISA using a gamma irradiated plate coated with purified GPI.
RESULTS: Twenty of 36 SLE patients were positive for at least one of the GPI-dependent aPL. Five of these 20 were also positive for aGPI. Another five of the 20 showed low GPI dependency aCL antibodies; however, three of these patients required GPI for binding to phosphatidylserine, phosphatidylinositol, or both.
CONCLUSION: We confirmed the existence of aGPI in patients with true GPI dependent aPL. From these results, we recommend the use of a gamma irradiated plate with GPI as antigen for the detection of true GPI dependent aPL or aGPI.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7880127      PMCID: PMC1005517          DOI: 10.1136/ard.54.1.73

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

Authors:  M Galli; P Comfurius; C Maassen; H C Hemker; M H de Baets; P J van Breda-Vriesman; T Barbui; R F Zwaal; E M Bevers
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

Review 2.  Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?

Authors:  D A Triplett
Journal:  Arch Pathol Lab Med       Date:  1993-01       Impact factor: 5.534

3.  Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.

Authors:  E Matsuura; Y Igarashi; M Fujimoto; K Ichikawa; T Suzuki; T Sumida; T Yasuda; T Koike
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I?

Authors:  A E Gharavi; E N Harris; L R Sammaritano; S S Pierangeli; J Wen
Journal:  J Lab Clin Med       Date:  1993-10

7.  Distinguishing beta 2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20.

Authors:  J Matsuda; N Saitoh; K Gohchi; M Gotoh; M Tsukamoto
Journal:  Br J Haematol       Date:  1993-12       Impact factor: 6.998

8.  Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus.

Authors:  J P Viard; Z Amoura; J F Bach
Journal:  Am J Med       Date:  1992-08       Impact factor: 4.965

9.  Detection of beta-2-glycoprotein-I-dependent antiphospholipid antibodies and anti-beta-2-glycoprotein-I antibody in patients with systemic lupus erythematosus and in patients with syphilis.

Authors:  J Matsuda; N Saitoh; K Gohchi; M Gotoh; M Tsukamoto
Journal:  Int Arch Allergy Immunol       Date:  1994       Impact factor: 2.749

10.  Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Authors:  E Matsuura; Y Igarashi; T Yasuda; D A Triplett; T Koike
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  1 in total

1.  Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.

Authors:  Virunya Parkpian; Oravan Verasertniyom; Monchand Vanichapuntu; Kitti Totemchokchyakarn; Kanokrat Nantiruj; Prapaporn Pisitkul; Pantep Angchaisuksiri; Napaporn Archararit; Bupha Rachakom; Katcharin Ayurachai; Suchela Janwityanujit
Journal:  Clin Rheumatol       Date:  2007-03-02       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.